JPS623814B2 - - Google Patents

Info

Publication number
JPS623814B2
JPS623814B2 JP54167550A JP16755079A JPS623814B2 JP S623814 B2 JPS623814 B2 JP S623814B2 JP 54167550 A JP54167550 A JP 54167550A JP 16755079 A JP16755079 A JP 16755079A JP S623814 B2 JPS623814 B2 JP S623814B2
Authority
JP
Japan
Prior art keywords
ceruloplasmin
administration
drug
side effects
antitumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54167550A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5690015A (en
Inventor
Mitsuyuki Shimizu
Masaaki Yamada
Shinichi Morisue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Priority to JP16755079A priority Critical patent/JPS5690015A/ja
Publication of JPS5690015A publication Critical patent/JPS5690015A/ja
Publication of JPS623814B2 publication Critical patent/JPS623814B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP16755079A 1979-12-25 1979-12-25 Preventive and remedy containing human ceruloplasmin as main component Granted JPS5690015A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16755079A JPS5690015A (en) 1979-12-25 1979-12-25 Preventive and remedy containing human ceruloplasmin as main component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16755079A JPS5690015A (en) 1979-12-25 1979-12-25 Preventive and remedy containing human ceruloplasmin as main component

Publications (2)

Publication Number Publication Date
JPS5690015A JPS5690015A (en) 1981-07-21
JPS623814B2 true JPS623814B2 (enExample) 1987-01-27

Family

ID=15851788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16755079A Granted JPS5690015A (en) 1979-12-25 1979-12-25 Preventive and remedy containing human ceruloplasmin as main component

Country Status (1)

Country Link
JP (1) JPS5690015A (enExample)

Also Published As

Publication number Publication date
JPS5690015A (en) 1981-07-21

Similar Documents

Publication Publication Date Title
Fiore-Donati et al. Leukaemogenesis by urethan in new-born Swiss mice
JPH02108636A (ja) 抗腫瘍性組合せ製剤
JPH0586379B2 (enExample)
EP0809512A1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
US5565558A (en) Thioretinaco ozonide and enhanced biological activity of thioretinaco ozonide in combination with interferon
CN107206053A (zh) 用于治疗血细胞减少症或减少血细胞减少症的持续时间的佛波醇酯组合物和方法
JP3697460B2 (ja) Ｈｇｆ含有製剤
EP0527852B2 (en) Method and compositions for treating injury
JPS6366128A (ja) 動物およびヒト癌の治療に用いられるｃ反応性タンパク質
EP0295559B1 (en) Pharmaceutical composition for the treatment of tumours
CN101346137A (zh) 含有孔布勒塔斯塔坦与抗癌剂的组合物
JP4800194B2 (ja) 乾癬の治療薬を製造するためのカハラリド化合物の使用
JPS623814B2 (enExample)
JPS6310728A (ja) ジサツカライド誘導体含有鎮痛剤
JPH07277964A (ja) 抗腫瘍剤
KR100514009B1 (ko) 1,2,4-벤조트리아진옥사이드제제
JP2770911B2 (ja) 抗ウイルス医薬組成物
JPWO2020264333A5 (enExample)
US5059418A (en) Synergistic effect of human recombinant interferon-beta on halogenated pyrimidines
RU94042656A (ru) Способ лечения первичного рака печени и набор для лечения первичного рака печени
CA2122024A1 (en) Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof
KR100564353B1 (ko) 방사선장해 예방 및 / 또는 치료제
CN105769849B (zh) 一种治疗卵巢癌的药物组合物
EP0140958B1 (en) Oncolytic drug combinations
KR20210039414A (ko) 암의 치료를 위한 병용 요법